Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Uher

Showing results (181-190 of 299) with videos related to

Pageof 30
Sort By:
Journal of Affective Disorders|October 11, 2011
Stressful life events and the serotonin transporter gene (5-HTT) in recurrent clinical depressionHelen L Fisher, Sarah Cohen-Woods, Georgina M Hosang, et al.
Plos One|December 12, 2024
Correction: Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1John-Jose Nunez, Teyden T Nguyen, Yihan Zhou, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 11, 2011
Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPRJana Strohmaier, Stefan Wüst, Rudolf Uher, et al.
Plos One|June 28, 2021
Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1John-Jose Nunez, Teyden T Nguyen, Yihan Zhou, et al.
Psychoneuroendocrinology|May 1, 2019
Polygenic risk for circulating reproductive hormone levels and their influence on hippocampal volume and depression susceptibilityDemelza M Smeeth, Danai Dima, Lisa Jones, et al.
The Journal of Clinical Psychiatry|November 15, 2023
Machine Learning Prediction of Quality of Life Improvement During Antidepressant Treatment of Patients With Major Depressive Disorder: A STAR*D and CAN-BIND-1 ReportTejas Phaterpekar, John-Jose Nunez, Emma Morton, et al.
JAMA Network Open|September 28, 2023
Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant MedicationBenjamin Schwartzmann, Prabhjot Dhami, Rudolf Uher, et al.
Scientific Reports|April 5, 2018
Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variablesRaquel Iniesta, Karen Hodgson, Daniel Stahl, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 5, 2022
"One Degree of Separation": A Mixed-Methods Evaluation of Canadian Mental Health Care User and Provider Experiences With Remote Care During COVID-19Amanda K Ceniti, Wegdan R Abdelmoemin, Keith Ho, et al.
Scientific Reports|May 24, 2023
Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression studyBenjamin Schwartzmann, Lena C Quilty, Prabhjot Dhami, et al.
Pageof 30

Showing results (181-190 of 299) with videos related to

Sort By:
Pageof 30
Journal of Affective Disorders|October 11, 2011
Stressful life events and the serotonin transporter gene (5-HTT) in recurrent clinical depressionHelen L Fisher, Sarah Cohen-Woods, Georgina M Hosang, et al.
Plos One|December 12, 2024
Correction: Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1John-Jose Nunez, Teyden T Nguyen, Yihan Zhou, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 11, 2011
Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPRJana Strohmaier, Stefan Wüst, Rudolf Uher, et al.
Plos One|June 28, 2021
Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1John-Jose Nunez, Teyden T Nguyen, Yihan Zhou, et al.
Psychoneuroendocrinology|May 1, 2019
Polygenic risk for circulating reproductive hormone levels and their influence on hippocampal volume and depression susceptibilityDemelza M Smeeth, Danai Dima, Lisa Jones, et al.
The Journal of Clinical Psychiatry|November 15, 2023
Machine Learning Prediction of Quality of Life Improvement During Antidepressant Treatment of Patients With Major Depressive Disorder: A STAR*D and CAN-BIND-1 ReportTejas Phaterpekar, John-Jose Nunez, Emma Morton, et al.
JAMA Network Open|September 28, 2023
Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant MedicationBenjamin Schwartzmann, Prabhjot Dhami, Rudolf Uher, et al.
Scientific Reports|April 5, 2018
Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variablesRaquel Iniesta, Karen Hodgson, Daniel Stahl, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 5, 2022
"One Degree of Separation": A Mixed-Methods Evaluation of Canadian Mental Health Care User and Provider Experiences With Remote Care During COVID-19Amanda K Ceniti, Wegdan R Abdelmoemin, Keith Ho, et al.
Scientific Reports|May 24, 2023
Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression studyBenjamin Schwartzmann, Lena C Quilty, Prabhjot Dhami, et al.
Pageof 30